Edesa Biotech, Inc. (NASDAQ:EDSA) is planning for a Phase 2 study of its anti-CXCL10 monoclonal antibody for the treatment of moderate-to-severe non-segmental vitiligo patients. Vitiligo is a ...

A higher intake of riboflavin was associated with a reduced risk of developing psoriasis, but no other single vitamin associations were observed.

Immutep’s efti with radiotherapy and pembrolizumab meets primary endpoint in phase II trials for soft tissue sarcoma ...

Find out more about chemokines and their role in inducing immune response against different diseases, particularly cancer.

The production of pro-inflammatory cytokines (IL6, IL12, and TNFα), anti-inflammatory cytokines (IL10), and chemokines (CXCL 8, CXCL10, and CCL3) in culture supernatants during each period of ...

Beta-cells produce proinflammatory CCL2, CCL5, and CXCL10 chemokines when exposed to inflammatory conditions or environmental triggers and can perpetuate the recruitment of immune cells to initiate ...

A novel machine learning model enhances colorectal cancer (CRC) prognosis and immunotherapy response prediction by ...

Apr. 28, 2025 — To help achieve more precise control of gene therapy, engineers have designed a new control circuit that can keep gene expression levels within a target range. The method could ...